Ahead of Solventum (SOLV) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Core Insights - Solventum (SOLV) is expected to report quarterly earnings of $1.45 per share, a decline of 7.1% year-over-year, with revenues projected at $2.12 billion, reflecting a 1.9% increase compared to the previous year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating analysts have reassessed their initial estimates [1][2] - The stock has returned -4% over the past month, underperforming the Zacks S&P 500 composite, which increased by 1% [5] Revenue Estimates - Analysts forecast 'Net Sales- MedSurg' to reach $1.18 billion, indicating a year-over-year change of +1.6% [3] - 'Net Sales- Purification and Filtration' is predicted to be $242.52 million, reflecting a year-over-year increase of +1.9% [4] - The consensus estimate for 'Net Sales- Health Information Systems' stands at $334.42 million, suggesting a +2% change from the year-ago quarter [4] - 'Net Sales- Dental Solutions' is expected to arrive at $332.90 million, indicating a +0.6% year-over-year change [4]